These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 37313861)

  • 1. Infantile spasms caused by
    Zhong L; Liu C; Lin L
    Appl Neuropsychol Child; 2023; 12(4):380-385. PubMed ID: 37313861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of infantile spasms.
    Hancock E; Osborne J; Milner P
    Cochrane Database Syst Rev; 2003; (3):CD001770. PubMed ID: 12917912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of West syndrome].
    Cvitanović-Sojat L; Gjergja R; Sabol Z; Hajnzić TF; Sojat T
    Acta Med Croatica; 2005; 59(1):19-29. PubMed ID: 15813352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical profile and treatment of infantile spasms using vigabatrin and ACTH--a developing country perspective.
    Ibrahim S; Gulab S; Ishaque S; Saleem T
    BMC Pediatr; 2010 Jan; 10():1. PubMed ID: 20078871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High vigabatrin dosage is associated with lower risk of infantile spasms relapse among children with tuberous sclerosis complex.
    Hussain SA; Schmid E; Peters JM; Goyal M; Bebin EM; Northrup H; Sahin M; Krueger DA; Wu JY;
    Epilepsy Res; 2018 Dec; 148():1-7. PubMed ID: 30296632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving Outcomes in Infantile Spasms: Role of Pharmacotherapy.
    Iyer A; Appleton R
    Paediatr Drugs; 2016 Oct; 18(5):357-66. PubMed ID: 27541933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epileptic spasms related to neuronal differentiation factor 2 (NEUROD2) mutation respond to combined vigabatrin and high dose prednisolone therapy.
    Sakpichaisakul K; Boonkrongsak R; Lertbutsayanukul P; Iemwimangsa N; Klumsathian S; Panthan B; Trachoo O
    BMC Neurol; 2022 Dec; 22(1):461. PubMed ID: 36494631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vigabatrin and mental retardation in tuberous sclerosis: infantile spasms versus focal seizures.
    Yum MS; Lee EH; Ko TS
    J Child Neurol; 2013 Mar; 28(3):308-13. PubMed ID: 22752486
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Chen S; Deng X; Xiong J; Chen B; He F; Yang L; Yang L; Peng J; Yin F
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Feb; 47(2):265-270. PubMed ID: 35545418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vigabatrin in the treatment of infantile spasms in tuberous sclerosis: literature review.
    Hancock E; Osborne JP
    J Child Neurol; 1999 Feb; 14(2):71-4. PubMed ID: 10073425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A lack of clinically apparent vision loss among patients treated with vigabatrin with infantile spasms: The UCLA experience.
    Schwarz MD; Li M; Tsao J; Zhou R; Wu YW; Sankar R; Wu JY; Hussain SA
    Epilepsy Behav; 2016 Apr; 57(Pt A):29-33. PubMed ID: 26921595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of infantile spasms.
    Hancock E; Osborne JP; Milner P
    Cochrane Database Syst Rev; 2002; (2):CD001770. PubMed ID: 12076419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of infantile spasms with sodium valproate followed by benzodiazepines.
    Auvichayapat N; Tassniyom S; Treerotphon S; Auvichayapat P
    J Med Assoc Thai; 2007 Sep; 90(9):1809-14. PubMed ID: 17957923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term outcome in children with infantile spasms treated with vigabatrin: a cohort of 180 patients.
    Djuric M; Kravljanac R; Tadic B; Mrlješ-Popovic N; Appleton RE
    Epilepsia; 2014 Dec; 55(12):1918-25. PubMed ID: 25377998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective preliminary analysis of the development of autism and epilepsy in children with infantile spasms.
    Askalan R; Mackay M; Brian J; Otsubo H; McDermott C; Bryson S; Boyd J; Snead C; Roberts W; Weiss S
    J Child Neurol; 2003 Mar; 18(3):165-70. PubMed ID: 12731640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vigabatrin as First-Line Treatment for Infantile Spasms Not Related to Tuberous Sclerosis Complex.
    Jones K; Go C; Boyd J; Ochi A; McCoy B; Puka K; Snead OC
    Pediatr Neurol; 2015 Aug; 53(2):141-5. PubMed ID: 26227562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vigabatrin with hormonal treatment versus hormonal treatment alone (ICISS) for infantile spasms: 18-month outcomes of an open-label, randomised controlled trial.
    O'Callaghan FJK; Edwards SW; Alber FD; Cortina Borja M; Hancock E; Johnson AL; Kennedy CR; Likeman M; Lux AL; Mackay MT; Mallick AA; Newton RW; Nolan M; Pressler R; Rating D; Schmitt B; Verity CM; Osborne JP;
    Lancet Child Adolesc Health; 2018 Oct; 2(10):715-725. PubMed ID: 30236380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A risk-benefit assessment of treatments for infantile spasms.
    Nabbout R
    Drug Saf; 2001; 24(11):813-28. PubMed ID: 11665869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of infantile spasms.
    Hancock EC; Osborne JP; Edwards SW
    Cochrane Database Syst Rev; 2008 Oct; (4):CD001770. PubMed ID: 18843624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain MRI findings with vigabatrin therapy: case report and literature review.
    Hussain K; Walsh TJ; Chazen JL
    Clin Imaging; 2016; 40(1):180-2. PubMed ID: 26526789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.